Online Program Home
My Program

CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Activity Details

350 Tue, 7/31/2018, 10:30 AM - 12:20 PM CC-West 304/305
Statistical Issues In Drug Development - 1 — Contributed Papers
Biopharmaceutical Section
Chair(s): Tian Dai
10:35 AM Reversals in Early Phase Dose Finding Trials

Bethany Horton, University of Virginia; John O'Quigley, Universit'e Pierre et Marie Curie, ; Mark Conaway, University of Virginia
10:50 AM The Emerging and Merging Fields of Benefit-Risk and Health Technology Assessments

Susan Talbot, Amgen Ltd; Shahrul Mt-Isa, Merck; Jixian Wang, Celgene
11:05 AM Application of Bayesian Approach in Evaluating Rare Adverse Events During a Clinical Study

Ying Grace Li, Eli Lilly and Company
11:20 AM Assessment of Treatment Effects in Single Cases and Small Groups: Assumptions, Logic, Algorithm, Computations
Lev Sverdlov
11:35 AM Monitoring Vaccine Safety by Studying Temporal Trend of Adverse Events Using VAERS

Jing Huang, University of Pennsylvania; Yi Cai, Pieces Technology; Jingcheng Du, University of Texas Health Science Center; Ruosha Li, University of Texas School of Public Health; Susan S Ellenberg, University of Pennsylvania; Sean Hennessy, University of Pennsylvania; Cui Tao, University of Texas Health Science Center; Yong Chen, University of Pennsylvania
11:50 AM Network Meta-Analysis: On the Use of the Standard Contrast-Based Approach in Disconnected Networks
Audrey BĂ©liveau, University of Waterloo; Paul Gustafson, University of British Columbia
12:05 PM Three Intervals Used in Setting Quality Specification Limits

Yi Tsong, CDER, FDA; Xin Hu, George Washington University